Darolutamide improves overall survival in patients with hormone-sensitive prostate cancer
1. Patients with hormone-sensitive prostate cancer receiving darolutamide, an androgen-receptor...
Read MoreMar 29, 2022
1. Patients with hormone-sensitive prostate cancer receiving darolutamide, an androgen-receptor...
Read MoreMar 28, 2022
Rapid Point-of-Care Genotyping to Avoid Aminoglycoside-Induced Ototoxicity in Neonatal Intensive...
Read MoreMar 24, 2022
2 Minute Medicine is pleased to announce that we are launching Wellness Check, a new series...
Read MoreMar 23, 2022
1. Homologous and heterologous booster vaccines had an acceptable safety profile in adults who...
Read MoreMar 23, 2022
1. In a cohort of about 80 adults who were born with very low birth weight (VLBW), total brain...
Read MoreMar 23, 2022
1. Both the Johnson & Johnson-Janssen (JJJ) and mRNA boosters provided an acceptable safety...
Read MoreMar 23, 2022
1. Cardiosphere-derived cell therapy (CAP-1002) slowed loss of upper limb function by 71% compared...
Read MoreMar 23, 2022
1. Patients with hereditary angioedema receiving donidalorsen showed reduced rates of angioedema...
Read MoreMar 23, 2022
1. mRNA booster vaccines for Covid-19 were highly effective against delta infection but less...
Read MoreMar 23, 2022
1. Ischemic stroke patients assigned to aspirin-only, heparin-only, or both, had worse Modified...
Read MoreMar 21, 2022
1. The adeno-associated virus 5 (AAV5)-based gene therapy, valoctocogene roxaparvovec...
Read MoreMar 21, 2022
1. More patients with systemic lupus erythematosus (SLE) who received high doses of iberdomide...
Read MoreMar 21, 2022
1. Hospitalized Covid-19 patients presenting from socially vulnerable neighborhoods had greater...
Read MoreMar 17, 2022
1. A retrospective analysis found that 29% of youth with benzodiazepine overdose and 25% of youth...
Read MoreMar 17, 2022
1. This systematic review and meta-analysis found a modest absolute risk reduction of 0.8% in...
Read MoreMar 17, 2022
1. For children with non-severe tuberculosis, 4 months of antituberculosis treatments was...
Read MoreMar 17, 2022
1. This systematic review and meta-analysis demonstrated that low- and no-calorie sweetened...
Read MoreMar 17, 2022
1. Garadacimab significantly reduced the number of monthly attacks in patients with hereditary...
Read MoreMar 16, 2022
1. In a retrospective cohort of about 11,000 children with at least one blood lead level above 4...
Read MoreMar 16, 2022
1. Three Covid-19 vaccines from Pfizer, Moderna, and Johnson & Johnson provided durable...
Read More